HKH
HARRIS KUO HAO HUANG
R&D Director
SHANXI ZHENDONG MEDPHARM CO.,LTD.
About me
Registration Type
ATT
Is member of
MPLA (Monophosphoryl Lipid A)
Exhibitorsis attending
Boosting DSCSA Regulatory Preparedness for FDA’s Drug Supply Chain Security Act Compliance with Copilot Integrated Generative AI/ML
Conference Theater 2
Difficulties Meeting US FDA Regulatory Requirements
Conference Theater 2
Purna Thakker · ADPT Solution
China Drug Master File (DMF) Comparing with U.S. and EU
Conference Theater 2
Using New Technologies to Improve Formulation of Poorly Soluble Drugs – Does It Matter?
Tuesday, May 7, 2024 7:50 PM to 7:55 PM
Conference Theater 2
Ole Wiborg · ZERION PHARMA, A/S
CrisBio®: A Novel, Natural and Scalable Protein Expression System
Tuesday, May 7, 2024 8:10 PM to 8:15 PM
Conference Theater 2